ALS (motor neurone disease) trials in Hungary

1 trial · From EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A clinical trial to learn how an investigational drug (MP-101) affects on the laboratory signs of the disease when given to Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s Disease (AD) patients

  Where

  Kistarcsa

  Age

  18 years and over

  People

  40

  Run by

  Mitochon Pharmaceuticals Inc.

  See details and how to join2023-507195-43-00 · EU 2023-507195-43-00